Compass Therapeutics, Inc. (CMPX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$66.49M | -34.7% |
| 2024 | -$49.38M | -16.2% |
| 2023 | -$42.49M | -8.3% |
| 2022 | -$39.23M | +52.3% |
| 2021 | -$82.18M | -178.6% |
| 2020 | -$29.50M | +15.1% |
| 2019 | -$34.74M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$66.49M | -34.7% |
| 2024 | -$49.38M | -16.2% |
| 2023 | -$42.49M | -8.3% |
| 2022 | -$39.23M | +52.3% |
| 2021 | -$82.18M | -178.6% |
| 2020 | -$29.50M | +15.1% |
| 2019 | -$34.74M | — |